Critical Appraisal of Literature Comparing Minimally Invasive Extraperitoneal and Transperitoneal Radical Prostatectomy: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Objectives: To systematically review studies comparing extraperitoneal (E-RP) and transperitoneal minimally invasive radical prostatectomy (T-RP).
Methods: The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines in September 2015. Several databases were searched including Medline and Scopus. Only studies comparing E-RP and T-RP (either laparoscopic or robot-assisted approach) were evaluated. The follow-up of the included patients had to be ≥6 months.
Results: In all, 1256 records were identified after the initial database search. Of these 20 studies (2580 patients) met the inclusion criteria. The hospital stay was significantly lower in the E-RP cohort, with a mean difference of -0.30 days (95% confidence interval [CI] -0.35, -0.24) for the laparoscopic group and 1.09 days (95% CI -1.47, -0.70) for the robotic group ( < 0.001). Early continence rates favoured the E-RP group, although this was statistically significant only in the laparoscopic group (odds ratio [OR] 2.52, 95% CI 1.72, 3.70; < 0.001). There was no statistically significant difference between the E-RP and T-RP cohorts for 12-month continence rates for both the laparoscopic (OR 1.55, 95% CI 0.89, 2.69; = 0.12) and robotic groups (OR 3.03, 95% CI 0.54, 16.85; = 0.21). The overall complication and ileus rates were significantly lower in the E-RP cohort for both the laparoscopic and robotic groups. The symptomatic lymphocele rate favoured the T-RP cohort, although this was statistically significant only in the laparoscopic group (OR 8.69, 95% CI 1.60, 47.17; = 0.01).
Conclusion: This review suggests that the extraperitoneal approach is associated with a shorter hospital stay, lower overall complication rate, and earlier return to continence when compared to the transperitoneal approach. The transperitoneal approach has a lower lymphocele rate.
Soda T, Otsuka H, Koike S, Okada T Int Urol Nephrol. 2023; 56(3):989-997.
PMID: 37907707 DOI: 10.1007/s11255-023-03859-9.
Purnomo S, Hamid A, Siregar M, Afriansyah A, Mirza H, Seno D Urol Res Pract. 2023; 49(5):285-292.
PMID: 37877876 PMC: 10646806. DOI: 10.5152/tud.2023.23008.
Luo C, Yang B, Ou Y, Wei Y, Wang Y, Yuan J J Robot Surg. 2023; 17(4):1659-1667.
PMID: 36947295 DOI: 10.1007/s11701-023-01576-0.
Ni K, Xue D, Li G Transl Cancer Res. 2022; 10(11):4694-4701.
PMID: 35116324 PMC: 8799017. DOI: 10.21037/tcr-21-898.
Boga M, Sonmez M, Karamik K, Yilmaz K, Savas M, Ates M Turk J Urol. 2020; 46(6):460-467.
PMID: 32833618 PMC: 7608535. DOI: 10.5152/tud.2020.20255.